The positive expression rate for HER2 was 71.1%, with a strong overexpression rate (3+ IHC) of 2.8% in endometrioid endometrial carcinoma (EEC) (Table 1 & Table 3). The gene discussed is ERBB2; the disease is exstrophy-epispadias complex.